ISCO Stock Overview - The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
PNK:ISCO

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

June 11, 2025

Description

Loading...

Returns 1M 6M 1Y 5Y 10Y
$ISCO N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A
Valuation P/E Ratio (TTM) P/S Ratio (TTM)
International Stem Cell Corporation Loading... Loading...
Sector Name Loading... N/A

Related

MYMXMymetics Corporation0.0%
RGRXRegeneRx Biopharmaceuticals, Inc.0.0%
CNBXCNBX Pharmaceuticals Inc.9.9%
HALBHalberd Corporation6.8%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue7M8M7M7M11M9M7M7M8M8M
Growth Rate-7.6%-5.1%4.1%48.7%-14.6%-24.7%0.7%14.0%-4.8%
EBITDA-9M-4M-5M-5M-3M-5M-3M-2M0M0M
EBITDA Margin-131.4%-54.2%-76.0%-61.9%-28.3%-57.4%-36.0%-22.9%0.3%-6.0%
Net Income-12M-3M-1M-6M-2M-4M-3M-1M0M0M
NI Margin-177.8%-34.9%-15.1%-81.4%-19.2%-45.9%-39.8%-14.5%-5.7%-1.7%
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.